Table 1 The relationship between the expression of FAM83B and the clinicopathological features in LUAD
From: FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway
FAM83B expression | ||||
|---|---|---|---|---|
Charactertistic | Total | High | Low | P |
n = 126 | n = 30 | N = 96 | ||
Gender | ||||
Female | 66 | 13 | 53 | 0.888 |
Male | 60 | 17 | 43 | |
Age(Y) | ||||
< 65 | 88 | 18 | 70 | 0.178 |
> 65 | 38 | 12 | 26 | |
Smoking history | ||||
Yes | 50 | 18 | 38 | 0.968 |
No | 76 | 12 | 58 | |
Clinical stage | ||||
I-IIA | 61 | 11 | 50 | 0.14 |
IIB-IV | 65 | 19 | 46 | |
LN metastasis | ||||
Yes | 60 | 11 | 41 | 0.048 |
No | 66 | 19 | 55 | |
Tumor differentiation | ||||
Well/Moderate | 82 | 20 | 62 | 0.835 |
Poor | 44 | 10 | 34 | |